Urol. praxi, 2015; 16(3): 99-101

Urolithiasis and obesity

MUDr.Peter Dančík1,2, MUDr.Jana Povová, Ph.D.1, Mgr.Kateřina Vařechová1,3, prof.MUDr.Vladimír Janout, CSc.1
1 Ústav epidemiologie a ochrany veřejného zdraví, Lékařská fakulta, Ostravská univerzita v Ostravě
2 Urologie, Městská nemocnice Ostrava, p. o.
3 Stipendista města Ostravy

Obesity represents one of today´s most serious health problems. It causes or it participates with other factors to the higher occurence of

urolithiasis. The determining metabolical factor leading to the higher prevalence of urolithiasis is low urine pH, which causes lower solubility

of uric acid. Its crystals function as promoters of oxalate lithiasis creation or directly to the creation of urate lithiasis. The therapy of urolithiasis

in obese patients is by introduction of modern endoscopic methods very safe and effective in spite of certain specifics in obese patients.

Keywords: urolithiasis, obesity, epidemiology, ethiopathogenesis, therapy

Published: June 30, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dančík P, Povová J, Vařechová K, Janout V. Urolithiasis and obesity. Urol. praxi. 2015;16(3):99-101.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Matoulek M, Svačina Š, Lajka J. Výskyt obezity a jejích komplikací v České republice. Vnitř Lék 2010; 56 (10): 1019-1027. Go to PubMed...
    2. Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron 1999; 81: 26-30. Go to original source... Go to PubMed...
    3. Ramey SL, Franke WD, Shelley MC. Relationship among risk factors for nephrolithiasis, cardiovascular disease, and ethnicity: Focus on a law enforcement cohort. AAOHN J. 2004; 52: 116-121. Go to original source... Go to PubMed...
    4. Ekuro WO, Tan YH, Young MD, et al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 2004; 172: 159-163. Go to original source... Go to PubMed...
    5. Powell CR, Stoller ML, Schwartz BF, et al. Impact of body weight on urinary electrolytes in urinary stone formers. Kidney Int 2004; 65: 1422-1425. Go to PubMed...
    6. Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 2002; 62: 971-979. Go to original source... Go to PubMed...
    7. Abate N, Chandalia M, Cabo-Chan AV, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis. Kidney Int 2004; 65: 386-392. Go to original source... Go to PubMed...
    8. Borghi L, Meschi T, Guerra A, et al. Essential arterial hypertension and stone disease. Kidney Int 1999; 55: 2397-2406. Go to original source... Go to PubMed...
    9. Delakas D, Karyotis I, Daskalopoulos G, Lianos E, Mavromanolakis E. Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second-generation lithotripter. J Endourol 2003; 4: 201-205. Go to original source... Go to PubMed...
    10. Carson CC, Danneberger JE, Weinert JL. Percutaneous lithotripsy in morbid obesity. J Urol 1988; 139: 243-245. Go to original source... Go to PubMed...
    11. Farber GJ, Goh M. Percutaneous nephrolithotripsy in the morbidly obese patient. Tech Urol 1997; 3: 89-95. Go to PubMed...
    12. Koo BC, Burtt G, Burgess NA. Percutaneous stone surgery in the obese: outcome stratified according to body mass index. BJU Int 2004; 93: 1296-1299. Go to original source... Go to PubMed...
    13. Nguyen TA, Belis JA. Endoscopic management of urolithiasis in the morbidly obese patient. J Endourol 1998; 12: 33-35. Go to original source... Go to PubMed...
    14. Andreoni C, Afane J, Olweny E, Clayman RV. Flexible ureteroscopic lithotripsy: first-line therapy for proximal ureteral and renal calculi in the morbidly obese and superobese patient. J Endourol. 2001; 15: 493-498. Go to original source... Go to PubMed...
    15. Dash AD, Schuster TG, Hollenbeck BK, et al. Ureteroscopy for urinary calculus disease in morbidly obese patients. Urology 2002; 60: 393-397. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.